Adenoviridae

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Berk, Arnold J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974682766     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (402)

1. Akusjarvi G. Temporal regulation of adenovirus major late alternative RNA splicing. Front Biosci 2008; 13: 5006-5015.
2. Akusjarvi G, Persson H. Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature 1981; 292: 420-426.
3. Akusjarvi G, Pettersson U. Sequence analysis of adenovirus DNA: complete nucleotide sequence of the spliced 5' noncoding region of adenovirus 2 hexon messenger RNA. Cell 1979; 16: 841-850.
4. Alber F, Dokudovskaya S, Veenhoff LM, et al. The molecular architecture of the nuclear pore complex. Nature 2007; 450: 695-701.
5. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
6. Amstutz B, Gastaldelli M, Kalin S, et al. Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J 2008; 27: 956-969.
7. Anderson CW, Baum PR, Gesteland RF. Processing of adenovirus 2-induced proteins. J Virol 1973; 12: 241-252.
8. Anderson CW, Young ME, Flint SJ. Characterization of the adenovirus 2 virion protein, mu. Virology 1989; 172: 506-512.
9. Anderson EJ. Prevention and treatment of viral diarrhea in pediatrics. Expert Rev Anti Infect Ther 2010; 8: 205-217.
10. Andersson MG, Haasnoot PC, Xu N, et al. Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 2005; 79: 9556-9565.
11. Angeletti PC, Engler JA. Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix. J Virol 1998; 72: 2896-2904.
12. Aoki K, Benko M, Davison AJ, et al. Towards an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology. J Virol 2011; 85: 5703-5704.
13. Araujo FD, Stracker TH, Carson CT, et al. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J Virol 2005; 79: 11382-11391.
14. Arnberg N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 2009; 19: 165-178.
15. Babich A, Feldman LT, Nevins JR, et al. Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination. Mol Cell Biol 1983; 3: 1212-1221.
16. Backstrom E, Kaufmann KB, Lan X, et al. Adenovirus L4-22K stimulates major late transcription by a mechanism requiring the intragenic late-specific transcription factor-binding site. Virus Res 2010; 151: 220-228.
17. Bagchi S, Raychaudhuri P, Nevins JR. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 1990; 62: 659-669.
18. Bailey CJ, Crystal RG, Leopold PL. Association of adenovirus with the microtubule organizing center. J Virol 2003; 77: 13275-13287.
19. Baker A, Rohleder KJ, Hanakahi LA, et al. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J Virol 2007; 81: 7034-7040.
20. Barbeau D, Charbonneau R, Whalen SG, et al. Functional interactions within adenovirus E1A protein complexes. Oncogene 1994; 9: 359-373.
21. Basner-Tschakarjan E, Gaffal E, O'Keeffe M, et al. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J Gene Med 2006; 8: 1300-1306.
22. Beltz GA, Flint SJ. Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus. J Mol Biol 1979; 131: 353-373.
23. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
24. Berget SM, Moore C, Sharp PA. Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A 1977; 74: 3171-3175.
25. Berkner KL, Sharp PA. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Res 1985; 13: 841-857.
26. Bewley MC, Springer K, Zhang YB, et al. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999; 286: 1579-1583.
27. Bhat G, SivaRaman L, Murthy S, et al. In vivo identification of multiple promoter domains of adenovirus EIIA-late promoter. EMBO J 1987; 6: 2045-2052.
28. Binger MH, Flint SJ. Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections. Virology 1984; 136: 387-403.
29. Blanchette P, Kindsmuller K, Groitl P, et al. Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J Virol 2008; 82: 2642-2651.
30. Bos JL, Polder LJ, Bernards R, et al. The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets. Cell 1981; 27: 121-131.
31. Bosher J, Robinson EC, Hay RT. Interactions between the adenovirus type 2 DNA polymerase and the DNA binding domain of nuclear factor I. New Biol 1990; 2: 1083-1090.
32. Botting CH, Hay RT. Characterisation of the adenovirus preterminal protein and its interaction with the POU homeodomain of NFIII (Oct-1). Nucleic Acids Res 1999; 27: 2799-2805.
33. Boudin ML, D'Halluin JC, Cousin C, et al. Human adenovirus type 2 protein IIIa. II. Maturation and encapsidation. Virology 1980; 101: 144-156.
34. Boyd JM, Subramanian T, Schaeper U, et al. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 1993; 12: 469-478.
35. Boyer TG, Martin ME, Lees E, et al. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature 1999; 399: 276-279.
36. Brestovitsky A, Sharf R, Mittelman K, et al. The adenovirus E4orf4 protein targets PP2A to the ACF chromatin-remodeling factor and induces cell death through regulation of SNF2h-containing complexes. Nucleic Acids Res 2011; 39: 6414-6427.
37. Bridge E, Pettersson U. Nuclear organization of replication and gene expression in adenovirus-infected cells. Curr Top Microbiol Immunol 1995; 199(Pt 1): 99-117.
38. Brown M, Weber J. Virion core-like organization of intranuclear adenovirus chromatin late in infection. Virology 1980; 107: 306-310.
39. Burmeister WP, Guilligay D, Cusack S, et al. Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites. J Virol 2004; 78: 7727-7736.
40. Cantin GT, Stevens JL, Berk AJ. Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proc Natl Acad Sci U S A 2003; 100: 12003-12008.
41. Carson CT, Orazio NI, Lee DV, et al. Mislocalization of the MRN complex prevents ATR signaling during adenovirus infection. EMBO J 2009; 28: 652-662.
42. Cerullo V, Seiler MP, Mane V, et al. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther 2007; 15: 378-385.
43. Challberg MD, Desiderio SV, Kelly TJ Jr. Adenovirus DNA replication in vitro: characterization of a protein covalently linked to nascent DNA strands. Proc Natl Acad Sci U S A 1980; 77: 5105-5109.
44. Challberg MD, Kelly TJ Jr. Adenovirus DNA replication in vitro. Proc Natl Acad Sci U S A 1979; 76: 655-659.
45. Chatterjee PK, Vayda ME, Flint SJ. Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J Mol Biol 1986; 188: 23-37.
46. Chen H, Vinnakota R, Flint SJ. Intragenic activating and repressing elements control transcription from the adenovirus IVa2 initiator. Mol Cell Biol 1994; 14: 676-685.
47. Chen J, Morral N, Engel DA. Transcription releases protein VII from adenovirus chromatin. Virology 2007; 369: 411-422.
48. Chen M, Mermod N, Horwitz MS. Protein-protein interactions between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complex. J Biol Chem 1990; 265: 18634-18642.
49. Chen PH, Ornelles DA, Shenk T. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J Virol 1993; 67: 3507-3514.
50. Chinnadurai G. Modulation of oncogenic transformation by the human adenovirus E1A C-terminal region. Curr Top Microbiol Immunol 2004; 273: 139-161.
51. Chinnadurai G. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 2009; 69: 731-734.
52. Chiu CY, Mathias P, Nemerow GR, et al. Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. J Virol 1999; 73: 6759-6768.
53. Chow LT, Gelinas RE, Broker TR, et al. An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA. Cell 1977; 12: 1-8.
54. Chow LT, Roberts JM, Lewis JB, et al. A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids. Cell 1977; 11: 819-836.
55. Christensen JB, Byrd SA, Walker AK, et al. Presence of the adenovirus IVa2 protein at a single vertex of the mature virion. J Virol 2008; 82: 9086-9093.
56. Chung SH, Frese KK, Weiss RS, et al. A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles. J Virol 2007; 81: 4787-4797.
57. Cleat PH, Hay RT. Co-operative interactions between NFI and the adenovirus DNA binding protein at the adenovirus origin of replication. EMBO J 1989; 8: 1841-1848.
58. Cohen CJ, Shieh JT, Pickles RJ, et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 2001; 98: 15191-15196.
59. Cotten M, Wagner E, Zatloukal K, et al. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci U S A 1992; 89: 6094-6098.
60. Croyle MA, Stone M, Amidon GL, et al. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther 1998; 5: 645-654.
61. Cuconati A, Mukherjee C, Perez D, et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev 2003; 17: 2922-2932.
62. Cuconati A, White E. Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 2002; 16: 2465-2478.
63. Cuesta R, Xi Q, Schneider RJ. Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J 2000; 19: 3465-3474.
64. Cuesta R, Xi Q, Schneider RJ. Preferential translation of adenovirus mRNAs in infected cells. Cold Spring Harb Symp Quant Biol 2001; 66: 259-267.
65. Cuesta R, Xi Q, Schneider RJ. Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein. J Virol 2004; 78: 7707-7716.
66. Dales S, Chardonnet Y. Early events in the interaction of adenoviruses with HeLa cells. IV. Association with microtubules and the nuclear pore complex during vectorial movement of the inoculum. Virology 1973; 56: 465-483.
67. Dallaire F, Blanchette P, Branton PE. A proteomic approach to identify candidate substrates of human adenovirus E4orf6-E1B55K and other viral cullin-based E3 ubiquitin ligases. J Virol 2009; 83: 12172-12184.
68. Daniell E. Genome structure of incomplete particles of adenovirus. J Virol 1976; 19: 685-708.
69. Dauksaite V, Akusjarvi G. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing. J Biol Chem 2002; 277: 12579-12586.
70. Davis R, Simon M, Davidson N. Electron microscope heteroduplex methods for mapping regions of base sequence homology in nucleic acids. Methods Enzymol 1971; 21: 413-428.
71. Davison AJ, Benko M, Harrach B. Genetic content and evolution of adenoviruses. J Gen Virol 2003; 84: 2895-2908.
72. de Jong RN, Meijer LA, van der Vliet PC. DNA binding properties of the adenovirus DNA replication priming protein pTP. Nucleic Acids Res 2003; 31: 3274-3286.
73. Debbas M, White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 1993; 7: 546-554.
74. Dekker J, Kanellopoulos PN, Loonstra AK, et al. Multimerization of the adenovirus DNA-binding protein is the driving force for ATP-independent DNA unwinding during strand displacement synthesis. EMBO J 1997; 16: 1455-1463.
75. Devaux C, Caillet-Boudin ML, Jacrot B, et al. Crystallization, enzymatic cleavage, and the polarity of the adenovirus type 2 fiber. Virology 1987; 161: 121-128.
76. Di Paolo NC, Miao EA, Iwakura Y, et al. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 2009; 31: 110-121.
77. Ding J, McGrath WJ, Sweet RM, et al. Crystal structure of the human adenovirus proteinase with its 11 amino acid cofactor. EMBO J 1996; 15: 1778-1783.
78. Dobner T, Horikoshi N, Rubenwolf S, et al. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 1996; 272: 1470-1473.
79. Dolph PJ, Huang JT, Schneider RJ. Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex. J Virol 1990; 64: 2669-2677.
80. Doucas V, Ishov AM, Romo A, et al. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 1996; 10: 196-207.
81. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003; 4: 457-467.
82. Dyson N, Guida P, Munger K, et al. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 1992; 66: 6893-6902.
83. Egan C, Bayley ST, Branton PE. Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene 1989; 4: 383-388.
84. Endter C, Kzhyshkowska J, Stauber R, et al. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci U S A 2001; 98: 11312-11317.
85. Enomoto T, Lichy JH, Ikeda JE, et al. Adenovirus DNA replication in vitro: purification of the terminal protein in a functional form. Proc Natl Acad Sci U S A 1981; 78: 6779-6783.
86. Evans JD, Hearing P. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J Virol 2005; 79: 6207-6215.
87. Everitt E, Lutter L, Philipson L. Structural proteins of adenoviruses. XII. Location and neighbor relationship among proteins of adenovirion type 2 as revealed by enzymatic iodination, immunoprecipitation and chemical cross-linking. Virology 1975; 67: 197-208.
88. Ewing SG, Byrd SA, Christensen JB, et al. Ternary complex formation on the adenovirus packaging sequence by the IVa2 and L4 22-kilodalton proteins. J Virol 2007; 81: 12450-12457.
89. Favier AL, Burmeister WPD, Chroboczek J. Unique physicochemical properties of human enteric Ad41 responsible for its survival and replication in the gastrointestinal tract. Virology 2004; 322: 93-104.
90. Fender P, Kidd AH, Brebant R, et al. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber. Virology 1995; 214: 110-117.
91. Fernandes ER, Rooney RJ. The adenovirus E1A-regulated transcription factor E4F is generated from the human homolog of nuclear factor phiAP3. Mol Cell Biol 1997; 17: 1890-1903.
92. Ferrari R, Pellegrini M, Horwitz GA, et al. Epigenetic reprogramming by adenovirus e1a. Science 2008; 321: 1086-1088.
93. Ferreon JC, Martinez-Yamout MA, Dyson HJ, et al. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc Natl Acad Sci U S A 2009; 106: 13260-13265.
94. Field J, Gronostajski RM, Hurwitz J. Properties of the adenovirus DNA polymerase. J Biol Chem 1984; 259: 9487-9495.
95. FitzGerald DJ, Padmanabhan R, Pastan I, et al. Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis. Cell 1983; 32: 607-617.
96. Flinterman M, Guelen L, Ezzati-Nik S, et al. E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem 2005; 280: 5945-5959.
97. Fowlkes DM, Shenk T. Transcriptional control regions of the adenovirus VAI RNA gene. Cell 1980; 22: 405-413.
98. Fredman JN, Engler JA. Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro. J Virol 1993; 67: 3384-3395.
99. Freimuth P, Philipson L, Carson SD. The coxsackievirus and adenovirus receptor. Curr Top Microbiol Immunol 2008; 323: 67-87.
100. Frese KK, Lee SS, Thomas DL, et al. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 2003; 22: 710-721.
101. Fuchs M, Gerber J, Drapkin R, et al. The p400 complex is an essential E1A transformation target. Cell 2001; 106: 297-307.
102. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408-1412.
103. Gahery-Segard H, Farace F, Godfrin D, et al. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 1998; 72: 2388-2397.
104. Gall JG, Crystal RG, Falck-Pedersen E. Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype. J Virol 1998; 72: 10260-10264.
105. Gastaldelli M, Imelli N, Boucke K, et al. Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 2008; 9: 2265-2278.
106. Ghosh MK, Harter ML. A viral mechanism for remodeling chromatin structure in G0 cells. Mol Cell 2003; 12: 255-260.
107. Gonzalez R, Huang W, Finnen R, et al. Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J Virol 2006; 80: 964-974.
108. Granberg F, Svensson C, Pettersson U, et al. Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture. Virology 2005; 343: 236-245.
109. Greber UF. Signalling in viral entry. Cell Mol Life Sci 2002; 59: 608-626.
110. Greber UF, Suomalainen M, Stidwill RP, et al. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J 1997; 16: 5998-6007.
111. Greber UF, Webster P, Weber J, et al. The role of the adenovirus protease on virus entry into cells. EMBO J 1996; 15: 1766-1777.
112. Greber UF, Willetts M, Webster P, et al. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993; 75: 477-486.
113. Green M, Daesch GE. Biochemical studies on adenovirus multiplication. II. Kinetics of nucleic acid and protein synthesis in suspension cultures. Virology 1961; 13: 169-176.
114. Greer AE, Hearing P, Ketner G. The adenovirus E4 11k protein binds and relocalizes the cytoplasmic P-body component Ddx6 to aggresomes. Virology 2011; 417: 161-168.
115. Guilfoyle R, Weinmann R. Control region for adenovirus VA RNA transcription. Proc Natl Acad Sci U S A 1981; 78: 3378-3382.
116. Gupta S, Mangel WF, McGrath WJ, et al. DNA binding provides a molecular strap activating the adenovirus proteinase. Mol Cell Proteomics 2004; 3: 950-959.
117. Gustin KE, Imperiale MJ. Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein. J Virol 1998; 72: 7860-7870.
118. Gustin KE, Lutz P, Imperiale MJ. Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection. J Virol 1996; 70: 6463-6467.
119. Gwizdek C, Ossareh-Nazari B, Brownawell AM, et al. Exportin-5 mediates nuclear export of minihelix-containing RNAs. J Biol Chem 2003; 278: 5505-5508.
120. Gyurcsik B, Haruki H, Takahashi T, et al. Binding modes of the precursor of adenovirus major core protein VII to DNA and template activating factor I: implication for the mechanism of remodeling of the adenovirus chromatin. Biochemistry 2006; 45: 303-313.
121. Hai TW, Liu F, Coukos WJ, et al. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev 1989; 3: 2083-2090.
122. Halbert DN, Cutt JR, Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol 1985; 56: 250-257.
123. Hammarskjold ML, Winberg G. Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome. Cell 1980; 20: 787-795.
124. Harada JN, Shevchenko A, Shevchenko A, et al. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol 2002; 76: 9194-9206.
125. Hasson TB, Ornelles DA, Shenk T. Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers. J Virol 1992; 66: 6133-6142.
126. Hasson TB, Soloway PD, Ornelles DA, et al. Adenovirus L1 52- and 55-kilodalton proteins are required for assembly of virions. J Virol 1989; 63: 3612-3621.
127. Hay RT. SUMO: a history of modification. Mol Cell 2005; 18: 1-12.
128. Hayes BW, Telling GC, Myat MM, et al. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J Virol 1990; 64: 2732-2742.
129. Hearing P, Samulski RJ, Wishart WL, et al. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol 1987; 61: 2555-2558.
130. Hearing P, Shenk T. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell 1983; 33: 695-703.
131. Herisse J, Rigolet M, de Dinechin SD, et al. Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region. Nucleic Acids Res 1981; 9: 4023-4042.
132. Hess M, Cuzange A, Ruigrok RW, et al. The avian adenovirus penton: two fibres and one base. J Mol Biol 1995; 252: 379-385.
133. Higashino F, Pipas JM, Shenk T. Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc Natl Acad Sci U S A 1998; 95: 15683-15687.
134. Hilleman MR, Werner JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954; 85: 183-188.
135. Hindley CE, Lawrence FJ, Matthews DA. A role for transportin in the nuclear import of adenovirus core proteins and DNA. Traffic 2007; 8: 1313-1322.
136. Hitt MM, Graham FL. Adenovirus vectors for human gene therapy. Adv Virus Res 2000; 55: 479-505.
137. Hong SS, Bardy M, Monteil M, et al. Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer. Viral Immunol 2000; 13: 353-371.
138. Hong SS, Szolajska E, Schoehn G, et al. The 100K-chaperone protein from adenovirus serotype 2 (subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses. J Mol Biol 2005; 352: 125-138.
139. Horwitz GA, Zhang K, McBrian MA, et al. Adenovirus small e1a alters global patterns of histone modification. Science 2008; 321: 1084-1085.
140. Horwitz MS, Scharff MD, Maizel JV Jr. Synthesis and assembly of adenovirus 2. I. Polypeptide synthesis, assembly of capsomeres, and morphogenesis of the virion. Virology 1969; 39: 682-694.
141. Hosokawa K, Sung MT. Isolation and characterization of an extremely basic protein from adenovirus type 5. J Virol 1976; 17: 924-934.
142. Howe JA, Mymryk JS, Egan C, et al. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc Natl Acad Sci U S A 1990; 87: 5883-5887.
143. Huang JT, Schneider RJ. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell 1991; 65: 271-280.
144. Huang W, Flint SJ. The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. J Virol 1998; 72: 225-235.
145. Hurst HC, Jones NC. Identification of factors that interact with the E1A-inducible adenovirus E3 promoter. Genes Dev 1987; 1: 1132-1146.
146. Iacobelli-Martinez M, Nemerow GR. Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J Virol 2007; 81: 1305-1312.
147. Ikeda JE, Enomoto T, Hurwitz J. Adenoviral protein-primed initiation of DNA chains in vitro. Proc Natl Acad Sci U S A 1982; 79: 2442-2446.
148. Ishibashi M, Maizel JV Jr. The polypeptides of adenovirus. VI. Early and late glycopolypeptides. Virology 1974; 58: 345-361.
149. Ito J, Braithwaite DK. Compilation and alignment of DNA polymerase sequences. Nucleic Acids Res 1991; 19: 4045-4057.
150. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11: 113-127.
151. Javier RT, Rice AP. Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol 2011; 85(22): 11544-11556.
152. Jones MS 2nd, Harrach B, Ganac RD, et al. New adenovirus species found in a patient presenting with gastroenteritis. J Virol 2007; 81: 5978-5984.
153. Kajon AE, Moseley JM, Metzgar D, et al. Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003). J Infect Dis 2007; 196: 67-75.
154. Kalin S, Amstutz B, Gastaldelli M, et al. Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J Virol 2010; 84: 5336-5350.
155. Kanopka A, Muhlemann O, Akusjarvi G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 1996; 381: 535-538.
156. Kanopka A, Muhlemann O, Petersen-Mahrt S, et al. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 1998; 393: 185-187.
157. Kao CC, Yew PR, Berk AJ. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 1990; 179: 806-814.
158. Karen KA, Hearing P. Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J Virol 2011; 85: 4135-4142.
159. Kasai Y, Chen H, Flint SJ. Anatomy of an unusual RNA polymerase II promoter containing a downstream TATA element. Mol Cell Biol 1992; 12: 2884-2897.
160. Katze MG, DeCorato D, Safer B, et al. Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J 1987; 6: 689-697.
161. Kehl SC, Kumar S. Utilization of nucleic acid amplification assays for the detection of respiratory viruses. Clin Lab Med 2009; 29: 661-671.
162. Kidd AH, Chroboczek J, Cusack S, et al. Adenovirus type 40 virions contain two distinct fibers. Virology 1993; 192: 73-84.
163. Kindsmuller K, Groitl P, Hartl B, et al. Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc Natl Acad Sci U S A 2007; 104: 6684-6689.
164. King AJ, Teertstra WR, Blanco L, et al. Processive proofreading by the adenovirus DNA polymerase. Association with the priming protein reduces exonucleolytic degradation. Nucleic Acids Res 1997; 25: 1745-1752.
165. Kitajewski J, Schneider RJ, Safer B, et al. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 1986; 45: 195-200.
166. Kitchen LW, Vaughn DW. Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases. Vaccine 2007; 25: 7017-7030.
167. Kleinberger T, Shenk T. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J Virol 1993; 67: 7556-7560.
168. Komatsu T, Haruki H, Nagata K. Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res 2011; 39: 889-901.
169. Koonin E, Senkevish, TG, Chernos VI. Gene A32 product of vaccina virus may be an ATPase involved in viral DNA packaging as indicated by sequence comparisons with other putative viral ATPases. Virus Genes 1993; 7: 89-94.
170. Kostura M, Mathews MB. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol Cell Biol 1989; 9: 1576-1586.
171. Kosulin K, Haberler C, Hainfellner JA, et al. Investigation of adenovirus occurrence in pediatric tumor entities. J Virol 2007; 81: 7629-7635.
172. Kovesdi I, Reichel R, Nevins JR. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 1986; 45: 219-228.
173. Kratzer F, Rosorius O, Heger P, et al. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 2000; 19: 850-857.
174. Kunz AN, Ottolini M. The role of adenovirus in respiratory tract infections. Curr Infect Dis Rep 2011; 12: 81-87.
175. Larsson S, Svensson C, Akusjarvi G. Control of adenovirus major late gene expression at multiple levels. J Mol Biol 1992; 225: 287-298.
176. Latorre IJ, Roh MH, Frese KK, et al. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci 2005; 118: 4283-4293.
177. Lechner RL, Kelly TJ Jr. The structure of replicating adenovirus 2 DNA molecules. Cell 1977; 12: 1007-1020.
178. Lee JO, Russo AA, Pavletich NP. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 1998; 391: 859-865.
179. Leen AM, Christin A, Khalil M, et al. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol 2008; 82: 546-554.
180. Leen AM, Sili U, Vanin EF, et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 2004; 104: 2432-2440.
181. Lehrer RI. Multispecific myeloid defensins. Curr Opin Hematol 2007; 14: 16-21.
182. Leong K, Lee W, Berk AJ. High-level transcription from the adenovirus major late promoter requires downstream binding sites for late-phase-specific factors. J Virol 1990; 64: 51-60.
183. Leopold PL, Kreitzer G, Miyazawa N, et al. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther 2000; 11: 151-165.
184. Lever MA, Th'ng JP, Sun X, et al. Rapid exchange of histone H1.1 on chromatin in living human cells. Nature 2000; 408: 873-876.
185. Levine AJ. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Virology 2009; 384: 285-293.
186. Li E, Stupack D, Klemke R, et al. Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol 1998; 72: 2055-2061.
187. Li Y, Graham C, Lacy S, et al. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 1993; 7: 2366-2377.
188. Lichy JH, Field J, Horwitz MS, et al. Separation of the adenovirus terminal protein precursor from its associated DNA polymerase: role of both proteins in the initiation of adenovirus DNA replication. Proc Natl Acad Sci U S A 1982; 79: 5225-5229.
189. Lichy JH, Horwitz MS, Hurwitz J. Formation of a covalent complex between the 80,000-dalton adenovirus terminal protein and 5'-dCMP in vitro. Proc Natl Acad Sci U S A 1981; 78: 2678-2682.
190. Lin J, Chen J, Elenbaas B, et al. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev 1994; 8: 1235-1246.
191. Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003; 102: 1114-1120.
192. Lion T, Kosulin K, Landlinger C, et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010; 24: 706-714.
193. Liu F, Green MR. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 1994; 368: 520-525.
194. Liu H, Jin L, Koh SB, et al. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 2010; 329: 1038-1043.
195. Liu H, Naismith JH, Hay RT. Adenovirus DNA replication. Curr Top Microbiol Immunol 2003; 272: 131-164.
196. Liu H, Wu L, Zhou ZH. Model of the trimeric fiber and its interactions with the pentameric penton base of human adenovirus by cryo-electron microscopy. J Mol Biol 2011; 406: 764-774.
197. Liu X, Marmorstein R. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev 2007; 21: 2711-2716.
198. Liu Y, Shevchenko A, Shevchenko A, Berk AJ. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J Virol 2005; 79: 14004-14016.
199. Logan J, Shenk T. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci U S A 1984; 81: 3655-3659.
200. Lortat-Jacob H, Chouin E, Cusack S, et al. Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions. J Biol Chem 2001; 276: 9009-9015.
201. Low HH, Lowe J. Dynamin architecture-from monomer to polymer. Curr Opin Struct Biol 2010; 20: 791-798.
202. Lowe SW, Ruley HE. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 1993; 7: 535-545.
203. Lu S, Cullen BR. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol 2004; 78: 12868-12876.
204. Lyons A, Longfield J, Kuschner R, et al. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine 2008; 26: 2890-2898.
205. Lyons RH, Ferguson BQ, Rosenberg M. Pentapeptide nuclear localization signal in adenovirus E1a. Mol Cell Biol 1987; 7: 2451-2456.
206. Ma HC, Hearing P. Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging. J Virol 2011; 85: 7849-7855.
207. Mabit H, Nakano MY, Prank U, et al. Intact microtubules support adenovirus and herpes simplex virus infections. J Virol 2002; 76: 9962-9971.
208. Mackey JK, Rigden PM, Green M. Do highly oncogenic group A human adenoviruses cause human cancer? Analysis of human tumors for adenovirus 12 transforming DNA sequences. Proc Natl Acad Sci U S A 1976; 73: 4657-4661.
209. Maizel JV Jr, White DO, Scharff MD. The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion. Virology 1968; 36: 126-136.
210. Mangel WF, McGrath WJ, Toledo DL, et al. Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 1993; 361: 274-275.
211. Marcellus RC, Chan H, Paquette D, et al. Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A. J Virol 2000; 74: 7869-7877.
212. Marin MC, Jost CA, Irwin MS, et al. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol 1998; 18: 6316-6324.
213. Martin ME, Berk AJ. Adenovirus E1B 55K represses p53 activation in vitro. J Virol 1998; 72: 3146-3154.
214. Martin-Fernandez M, Longshaw SV, Kirby I, et al. Adenovirus type-5 entry and disassembly followed in living cells by FRET, fluorescence anisotropy, and FLIM. Biophys J 2004; 87: 1316-1327.
215. Marton MJ, Baim SB, Ornelles DA, et al. The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. J Virol 1990; 64: 2345-2359.
216. Matsumoto K, Nagata K, Miyaji-Yamaguchi M, et al. Sperm chromatin decondensation by template activating factor I through direct interaction with basic proteins. Mol Cell Biol 1999; 19: 6940-6952.
217. Matthews DA, Russell WC. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli. J Gen Virol 1998; 79(Pt 7): 1671-1675.
218. Maxfield LF, Spector DJ. Readthrough activation of early adenovirus E1b gene transcription. J Virol 1997; 71: 8321-8329.
219. Meier O, Boucke K, Hammer SV, et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol 2002; 158: 1119-1131.
220. Meier O, Greber UF. Adenovirus endocytosis. J Gene Med 2004;6 Suppl 1:S152-S163.
221. Metzgar D, Osuna M, Kajon AE, et al. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007; 196: 1465-1473.
222. Miller DL, Myers CL, Rickards B, et al. Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival. Genome Biol 2007; 8: R58.
223. Misteli T, Gunjan A, Hock R, et al. Dynamic binding of histone H1 to chromatin in living cells. Nature 2000; 408: 877-881.
224. Montell C, Courtois G, Eng C, et al. Complete transformation by adenovirus 2 requires both E1A proteins. Cell 1984; 36: 951-961.
225. Montell C, Fisher EF, Caruthers MH, et al. Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site. Nature 1982; 295: 380-384.
226. Morris SJ, Scott GE, Leppard KN. Adenovirus late-phase infection is controlled by a novel L4 promoter. J Virol 2010; 84: 7096-7104.
227. Mul YM, Van der Vliet PC. Nuclear factor I enhances adenovirus DNA replication by increasing the stability of a preinitiation complex. EMBO J 1992; 11: 751-760.
228. Mul YM, Verrijzer CP, van der Vliet PC. Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication. J Virol 1990; 64: 5510-5518.
229. Muller S, Dobner T. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53. Cell Cycle 2008; 7: 754-758.
230. Muruve DA, Petrilli V, Zaiss AK, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008; 452: 103-107.
231. Nagata K, Guggenheimer RA, Hurwitz J. Adenovirus DNA replication in vitro: synthesis of full-length DNA with purified proteins. Proc Natl Acad Sci U S A 1983; 80: 4266-4270.
232. Nakano MY, Boucke K, Suomalainen M, et al. The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J Virol 2000; 74: 7085-7095.
233. Neill SD, Hemstrom C, Virtanen A, et al. An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. Proc Natl Acad Sci U S A 1990; 87: 2008-2012.
234. Nemerow GR, Pache L, Reddy V, et al. Insights into adenovirus host cell interactions from structural studies. Virology 2009; 384: 380-388.
235. Nemerow GR, Stewart PL. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 1999; 63: 725-734.
236. Nevins JR, Darnell JE. Groups of adenovirus type 2 mRNA's derived from a large primary transcript: probable nuclear origin and possible common 3' ends. J Virol 1978; 25: 811-823.
237. Nevins JR, Ginsberg HS, Blanchard JM, et al. Regulation of the primary expression of the early adenovirus transcription units. J Virol 1979; 32: 727-733.
238. Nevins JR, Wilson MC. Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature 1981; 290: 113-118.
239. Nguyen EK, Nemerow GR, Smith JG. Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol 2010; 84: 4041-4049.
240. Nibu Y, Zhang H, Levine M. Interaction of short-range repressors with Drosophila CtBP in the embryo. Science 1998; 280: 101-104.
241. Obert S, O'Connor RJ, Schmid S, et al. The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex. Mol Cell Biol 1994; 14: 1333-1346.
242. O'Brien TP, Jeng BH, McDonald M, et al. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin 2009; 25: 1953-1961.
243. O'Malley RP, Duncan RF, Hershey JW, et al. Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells. Virology 1989; 168: 112-118.
244. O'Neill EA, Fletcher C, Burrow CR, et al. Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III. Science 1988; 241: 1210-1213.
245. Onion D, Crompton LJ, Milligan DW, et al. The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J Gen Virol 2007; 88: 2417-2425.
246. Oosterom-Dragon EA, Ginsberg HS. Purification and preliminary immunological characterization of the type 5 adenovirus, nonstructural 100,000-dalton protein. J Virol 1980; 33: 1203-1207.
247. Orazio NI, Naeger CM, Karlseder J, et al. The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection. J Virol 2011; 85: 1887-1892.
248. O'Shea C, Klupsch K, Choi S, et al. Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J 2005; 24: 1211-1221.
249. Ostapchuk P, Almond M, Hearing P. Characterization of Empty adenovirus particles assembled in the absence of a functional adenovirus IVa2 protein. J Virol 2011; 85: 5524-5531.
250. Ostapchuk P, Anderson ME, Chandrasekhar S, et al. The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome. J Virol 2006; 80: 6973-6981.
251. Ostapchuk P, Hearing P. Adenovirus IVa2 protein binds ATP. J Virol 2008; 82: 10290-10294.
252. Ostapchuk P, Hearing P. Control of adenovirus packaging. J Cell Biochem 2005; 96: 25-35.
253. Ostapchuk P, Hearing P. Regulation of adenovirus packaging. Curr Top Microbiol Immunol 2003; 272: 165-185.
254. Ostapchuk P, Yang J, Auffarth E, et al. Functional interaction of the adenovirus IVa2 protein with adenovirus type 5 packaging sequences. J Virol 2005; 79: 2831-2838.
255. Panzeter PL, Ringer DP. DNA precursors are channelled to nuclear matrix DNA replication sites. Biochem J 1993; 293(Pt 3): 775-779.
256. Pardo-Mateos A, Young CS. Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo. Virology 2004; 327: 50-59.
257. Parks CL, Banerjee S, Spector DJ. Organization of the transcriptional control region of the E1b gene of adenovirus type 5. J Virol 1988; 62: 54-67.
258. Parks RJ, Chen L, Anton M, et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 1996; 93: 13565-13570.
259. Pelka P, Ablack JN, Shuen M, et al. Identification of a second independent binding site for the pCAF acetyltransferase in adenovirus E1A. Virology 2009; 391: 90-98.
260. Pelka P, Ablack JN, Torchia J, et al. Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP. Nucleic Acids Res 2009; 37: 1095-1106.
261. Pennella MA, Liu Y, Woo JL, et al. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J Virol 2010; 84: 12210-12225.
262. Perez-Berna AJ, Marabini R, Scheres SH, et al. Structure and uncoating of immature adenovirus. J Mol Biol 2009; 392: 547-557.
263. Perez-Romero P, Tyler RE, Abend JR, et al. Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro. J Virol 2005; 79: 2366-2374.
264. Perricaudet M, Akusjarvi G, Virtanen A, et al. Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature 1979; 281: 694-696.
265. Persson BD, Reiter DM, Marttila M, et al. Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat Struct Mol Biol 2007; 14: 164-166.
266. Petrilli V, Dostert C, Muruve DA, et al. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-622.
267. Pichla-Gollon SL, Drinker M, Zhou X, et al. Structure-based identification of a major neutralizing site in an adenovirus hexon. J Virol 2007; 81: 1680-1689.
268. Pilder S, Moore M, Logan J, et al. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol 1986; 6: 470-476.
269. Prage L, Pettersson U, Hoglund S, et al. Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion. Virology 1970; 42: 341-358.
270. Pruijn JM, van der Vliet PC, Dathan NA, et al. Anti-OTF-1 antibodies inhibit NFIII stimulation of in vitro adenovirus DNA replication. Nucleic Acids Res 1989; 17: 1845-1863.
271. Puntener D, Engelke MF, Ruzsics Z, et al. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J Virol 2011; 85: 481-496.
272. Querido E, Blanchette P, Yan Q, et al. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 2001; 15: 3104-3117.
273. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-158.
274. Rasti M, Grand RJ, Mymryk JS, et al. Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A. J Virol 2005; 79: 5594-5605.
275. Reddy VS, Natchiar SK, Stewart PL, et al. Crystal structure of human adenovirus at 3.5 A resolution. Science 2010; 329: 1071-1075.
276. Reich PR, Forget BG, Weissman SM. RNA of low molecular weight in KB cells infected with adenovirus type 2. J Mol Biol 1966; 17: 428-439.
277. Reichel PA, Merrick WC, Siekierka J, et al. Regulation of a protein synthesis initiation factor by adenovirus virus-associated RNA. Nature 1985; 313: 196-200.
278. Roberts DM, Nanda A, Havenga MJ, et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 2006; 441: 239-243.
279. Roberts RJ, O'Neill KE, Yen CT. DNA sequences from the adenovirus 2 genome. J Biol Chem 1984; 259: 13968-13975.
280. Robinson CM, Singh G, Henquell C, et al. Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality. Virology 2010; 409: 141-147.
281. Roelvink PW, Lizonova A, Lee JG, et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998; 72: 7909-7915.
282. Ross PJ, Kennedy MA, Christou C, et al. Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression. J Virol 2011; 85: 3950-3958.
283. Rowe WP, Huebner RJ, Gilmore LK, et al. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953; 84: 570-573.
284. Russell WC, Laver WG, Sanderson PJ. Internal components of adenovirus. Nature 1968; 219: 1127-1130.
285. Rux JJ, Burnett RM. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol Ther 2000; 1: 18-30.
286. Rux JJ, Kuser PR, Burnett RM. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods. J Virol 2003; 77: 9553-9566.
287. Saban SD, Silvestry M, Nemerow GR, et al. Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol 2006; 80: 12049-12059.
288. San Martin C, Burnett RM. Structural studies on adenoviruses. Curr Top Microbiol Immunol 2003; 272: 57-94.
289. Sarnow P, Ho YS, Williams J, et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982; 28: 387-394.
290. Schaack J, Ho WY, Freimuth P, et al. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev 1990; 4: 1197-1208.
291. Schaeper U, Boyd JM, Verma S, et al. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A 1995; 92: 10467-10471.
292. Schneider RJ, Safer B, Munemitsu SM, et al. Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci U S A 1985; 82: 4321-4325.
293. Schneider RJ, Weinberger C, Shenk T. Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells. Cell 1984; 37: 291-298.
294. Schwartz RA, Lakdawala SS, Eshleman HD, et al. Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates. J Virol 2008; 82: 9043-9055.
295. Segerman A, Atkinson JP, Marttila M, et al. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 2003; 77: 9183-9191.
296. Sha J, Ghosh MK, Zhang K, et al. E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase. J Virol 2010; 84: 4050-4059.
297. Shaw AR, Ziff EB. Transcripts from the adenovirus-2 major late promoter yield a single early family of 3' coterminal mRNAs and five late families. Cell 1980; 22: 905-916.
298. Shu LM, Horwitz MS, Engler JA. Expression of enzymatically active adenovirus DNA polymerase from cloned DNA requires sequences upstream of the main open reading frame. Virology 1987; 161: 520-526.
299. Silvestry M, Lindert S, Smith JG, et al. Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J Virol 2009; 83: 7375-7383.
300. Sirena D, Lilienfeld B, Eisenhut M, et al. The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol 2004; 78: 4454-4462.
301. SivaRaman L, Thimmappaya B. Two promoter-specific host factors interact with adjacent sequences in an EIA-inducible adenovirus promoter. Proc Natl Acad Sci U S A 1987; 84: 6112-6116.
302. Smart JE, Stillman BW. Adenovirus terminal protein precursor. Partial amino acid sequence and the site of covalent linkage to virus DNA. J Biol Chem 1982; 257: 13499-13506.
303. Smith JG, Cassany A, Gerace L, et al. Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J Virol 2008; 82: 6492-6500.
304. Smith JG, Nemerow GR. Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe 2008; 3: 11-19.
305. Smith JG, Silvestry M, Lindert S, et al. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog 2010; 6: e1000959.
306. Sollerbrant K, Chinnadurai G, Svensson C. The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res 1996; 24: 2578-2584.
307. Soloway PD, Shenk T. The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of L1 mRNAs. J Virol 1990; 64: 551-558.
308. Soria C, Estermann FE, Espantman KC, et al. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 2010; 466: 1076-1081.
309. Spector DJ, Johnson JS, Baird NL, et al. Adenovirus type 5 DNA-protein complexes from formaldehyde cross-linked cells early after infection. Virology 2003; 312: 204-212.
310. Spencer SL, Sorger PK. Measuring and modeling apoptosis in single cells. Cell 2011; 144: 926-939.
311. Steegenga WT, Shvarts A, Riteco N, et al. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins. Mol Cell Biol 1999; 19: 3885-3894.
312. Stephens C, Harlow E. Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. EMBO J 1987; 6: 2027-2035.
313. Stevens JL, Cantin GT, Wang G, et al. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 2002; 296: 755-758.
314. Stewart PL, Chiu CY, Huang S, et al. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J 1997; 16: 1189-1198.
315. Stewart PL, Nemerow GR. Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol 2007; 15: 500-507.
316. Stillman BW, Lewis JB, Chow LT, et al. Identification of the gene and mRNA for the adenovirus terminal protein precursor. Cell 1981; 23: 497-508.
317. Stillman BW, Tamanoi F, Mathews MB. Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication. Cell 1982; 31: 613-623.
318. Stracker TH, Carson CT, Weitzman MD. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002; 418: 348-352.
319. Strom AC, Ohlsson P, Akusjarvi G. AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain. J Virol 1998; 72: 5978-5983.
320. Strunze S, Trotman LC, Boucke K, et al. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol Biol Cell 2005; 16: 2999-3009.
321. Stuiver MH, van der Vliet PC. Adenovirus DNA-binding protein forms a multimeric protein complex with double-stranded DNA and enhances binding of nuclear factor I. J Virol 1990; 64: 379-386.
322. Sumida SM, Truitt DM, Lemckert AA, et al. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol 2005; 174: 7179-7185.
323. Suomalainen M, Nakano MY, Boucke K, et al. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J 2001; 20: 1310-1319.
324. Svensson C, Pettersson U, Akusjarvi G. Splicing of adenovirus 2 early region 1A mRNAs is non-sequential. J Mol Biol 1983; 165: 475-495.
325. Tal J, Craig EA, Raskas HJ. Sequence relationships between adenovirus 2 early RNA and viral RNA size classes synthesized at 18 hours after infection. J Virol 1975; 15: 137-144.
326. Tamanini A, Nicolis E, Bonizzato A, et al. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol 2006; 80: 11241-11254.
327. Tang J, Olive M, Champagne K, et al. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther 2004; 11: 1408-1415.
328. Tang J, Olive M, Pulmanausahakul R, et al. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology 2006; 350: 312-322.
329. Tate JE, Bunning ML, Lott L, et al. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis 2009; 199: 1419-1426.
330. Tebruegge M, Curtis N. Adenovirus infection in the immunocompromised host. Adv Exp Med Biol 2010; 659: 153-174.
331. Temperley SM, Hay RT. Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins. EMBO J 1992; 11: 761-768.
332. Thimmappaya B, Weinberger C, Schneider RJ, et al. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 1982; 31: 543-551.
333. Thomas GP, Mathews MB. DNA replication and the early to late transition in adenovirus infection. Cell 1980; 22: 523-533.
334. Tibbetts C. Viral DNA sequences from incomplete particles of human adenovirus type 7. Cell 1977; 12: 243-249.
335. Tihanyi K, Bourbonniere M, Houde A, et al. Isolation and properties of adenovirus type 2 proteinase. J Biol Chem 1993; 268: 1780-1785.
336. Tollefson AE, Scaria A, Hermiston TW, et al. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol 1996; 70: 2296-2306.
337. Tollefson AE, Scaria A, Saha SK, et al. The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. J Virol 1992; 66: 3633-3642.
338. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997; 94: 3352-3356.
339. Toogood CI, Crompton J, Hay RT. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J Gen Virol 1992; 73(Pt 6): 1429-1435.
340. Tormanen H, Backstrom E, Carlsson A, et al. L4-33K, an adenovirus-encoded alternative RNA splicing factor. J Biol Chem 2006; 281: 36510-36517.
341. Trentin JJ, Yabe Y, Taylor G. The quest for human cancer viruses. Science 1962; 137: 835-841.
342. Tribouley C, Lutz P, Staub A, et al. The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J Virol 1994; 68: 4450-4457.
343. Trotman LC, Mosberger N, Fornerod M, et al. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol 2001; 3: 1092-1100.
344. Tucker PA, Tsernoglou D, Tucker AD, et al. Crystal structure of the adenovirus DNA binding protein reveals a hook-on model for cooperative DNA binding. EMBO J 1994; 13: 2994-3002.
345. Tyler RE, Ewing SG, Imperiale MJ. Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein. J Virol 2007; 81: 3447-3454.
346. Ullman AJ, Hearing P. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol 2008; 82: 7325-7335.
347. van den Heuvel S, Dyson NJ. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 2008; 9: 713-724.
348. van der Vliet PC, Levine AJ. DNA-binding proteins specific for cells infected by adenovirus. Nat New Biol 1973; 246: 170-174.
349. van Leeuwen HC, Rensen M, van der Vliet PC. The Oct-1 POU homeodomain stabilizes the adenovirus preinitiation complex via a direct interaction with the priming protein and is displaced when the replication fork passes. J Biol Chem 1997; 272: 3398-3405.
350. van Oostrum J, Burnett RM. Molecular composition of the adenovirus type 2 virion. J Virol 1985; 56: 439-448.
351. van Raaij MJ, Louis N, Chroboczek J, et al. Structure of the human adenovirus serotype 2 fiber head domain at 1.5 A resolution. Virology 1999; 262: 333-343.
352. van Raaij MJ, Mitraki A, Lavigne G, et al. A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 1999; 401: 935-938.
353. Velicer LF, Ginsberg HS. Synthesis, transport, and morphogenesis of type adenovirus capsid proteins. J Virol 1970; 5: 338-352.
354. Virtanen A, Gilardi P, Naslund A, et al. mRNAs from human adenovirus 2 early region 4. J Virol 1984; 51: 822-831.
355. Wada T, Watanabe H, Usuda Y, et al. Different biological activities of the hetero- and homodimers formed by the 47- and 43-kilodalton proteins of transcription factor ATF/E4TF3. J Virol 1991; 65: 557-564.
356. Waddington SN, McVey JH, Bhella D, et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008; 132: 397-409.
357. Walkiewicz MP, Morral N, Engel DA. Accurate single-day titration of adenovirus vectors based on equivalence of protein VII nuclear dots and infectious particles. J Virol Methods 2009; 159: 251-258.
358. Walters RW, Freimuth P, Moninger TO, et al. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 2002; 110: 789-799.
359. Wang G, Balamotis MA, Stevens JL, et al. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol Cell 2005; 17: 683-694.
360. Wang HG, Moran E, Yaciuk P. E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J Virol 1995; 69: 7917-7924.
361. Wang K, Huang S, Kapoor-Munshi A, et al. Adenovirus internalization and infection require dynamin. J Virol 1998; 72: 3455-3458.
362. Wang X, Bergelson JM. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J Virol 1999; 73: 2559-2562.
363. Watanabe H, Imai T, Sharp PA, et al. Identification of two transcription factors that bind to specific elements in the promoter of the adenovirus early-region 4. Mol Cell Biol 1988; 8: 1290-1300.
364. Weber J. Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol 1976; 17: 462-471.
365. Weber J, Philipson L. Protein composition of adenovirus nucleoprotein complexes extracted from infected cells. Virology 1984; 136: 321-327.
366. Weber JM. Synthesis and assay of recombinant adenovirus protease. Methods Mol Med 2007; 131: 251-255.
367. Webster A, Hay RT, Kemp G. The adenovirus protease is activated by a virus-coded disulphide-linked peptide. Cell 1993; 72: 97-104.
368. Weinmann R, Raskas HJ, Roeder RG. Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection. Proc Natl Acad Sci U S A 1974; 71: 3426-3439.
369. White E. Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 2001; 20: 7836-7846.
370. Whyte P, Buchkovich KJ, Horowitz JM, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124-129.
371. Whyte P, Williamson NM, Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell 1989; 56: 67-75.
372. Wickham TJ, Mathias P, Cheresh DA, et al. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
373. Wienzek S, Roth J, Dobbelstein M. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol 2000; 74: 193-202.
374. Wiethoff CM, Wodrich H, Gerace L, et al. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 2005; 79: 1992-2000.
375. Williams JL, Garcia J, Harrich D, et al. Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs. EMBO J 1990; 9: 4435-4442.
376. Wimmer P, Schreiner S, Everett RD, et al. SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. Oncogene 2010; 29: 5511-5522.
377. Winberg G, Shenk T. Dissection of overlapping functions within the adenovirus type 5 E1A gene. EMBO J 1984; 3: 1907-1912.
378. Wodrich H, Cassany A, D'Angelo MA, et al. Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol 2006; 80: 9608-9618.
379. Woo JL, Berk AJ. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J Virol 2007; 81: 575-587.
380. Wu E, Pache L, Von Seggern DJ, et al. Flexibility of the adenovirus fiber is required for efficient receptor interaction. J Virol 2003; 77: 7225-7235.
381. Wu E, Trauger SA, Pache L, et al. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol 2004; 78: 3897-3905.
382. Wu L, Berk A. Constraints on spacing between transcription factor binding sites in a simple adenovirus promoter. Genes Dev 1988; 2: 403-411.
383. Xi Q, Cuesta R, Schneider RJ. Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs. J Virol 2005; 79: 5676-5683.
384. Xi Q, Cuesta R, Schneider RJ. Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes Dev 2004; 18: 1997-2009.
385. Xue Y, Johnson JS, Ornelles DA, et al. Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J Virol 2005; 79: 2474-2483.
386. Yew PR, Berk AJ. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 1992; 357: 82-85.
387. Yew PR, Liu X, Berk AJ. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev 1994; 8: 190-202.
388. Yi R, Qin Y, Macara IG, et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17: 3011-3016.
389. Ying B, Wold WS. Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B. Virology 2003; 313: 224-234.
390. Yueh A, Schneider RJ. Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev 1996; 10: 1557-1567.
391. Zantema A, Fransen JA, Davis-Olivier A, et al. Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 1985; 142: 44-58.
392. Zhang W, Arcos R. Interaction of the adenovirus major core protein precursor, pVII, with the viral DNA packaging machinery. Virology 2005; 334: 194-202.
393. Zhang W, Imperiale MJ. Interaction of the adenovirus IVa2 protein with viral packaging sequences. J Virol 2000; 74: 2687-2693.
394. Zhang W, Imperiale MJ. Requirement of the adenovirus IVa2 protein for virus assembly. J Virol 2003; 77: 3586-3594.
395. Zhang Z, Mui MZ, Chan F, et al. Genetic analysis of B55alpha/Cdc55 protein phosphatase 2A subunits: association with the adenovirus E4orf4 protein. J Virol 2011; 85: 286-295.
396. Zhao H, Granberg F, Elfineh L, et al. Strategic attack on host cell gene expression during adenovirus infection. J Virol 2003; 77: 11006-11015.
397. Zheng N, Schulman BA, Song L, et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416: 703-709.
398. Zhu J, Huang X, Yang Y. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol 2007; 81: 3170-3180.
399. Ziff E, Fraser N. Adenovirus type 2 late mRNA's: structural evidence for 3'-coterminal species. J Virol 1978; 25: 897-906.
400. Ziff EB, Evans RM. Coincidence of the promoter and capped 5' terminus of RNA from the adenovirus 2 major late transcription unit. Cell 1978; 15: 1463-1475.
401. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
402. Zubieta C, Schoehn G, Chroboczek J, et al. The structure of the human adenovirus 2 penton. Mol Cell 2005; 17: 121-135.